Global Bipolar Disorder Therapeutics Market 2015-2019 with Allergan, AstraZeneca, BMS, Eli Lilly, GlaxoSmithKline & Janssen Pharmaceuticals Dominating

DUBLIN, January 8, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/h5sn6k/global_bipolar) has announced the addition of the "Global Bipolar Disorder Therapeutics Market 2015-2019" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The report forecasts the global bipolar disorder therapeutics market to grow at a CAGR of 2.24% over the period 2014-2019.

The rise in awareness about the disorder has led to increased understanding among the public. This has led to a rise in the number of individuals seeking medical attention for the treatment of the disorder. Also, strategic alliances formed between vendors help in increased penetration of the drugs in the market and increase market share.

According to the report, an increase in the patient pool has been observed due to the increased identification of the disease because of awareness programs. Current treatment options do not provide a cure for the disorder, therefore, there is a significant unmet need in the market. Drugs that can cause remission of depression and mania in patients are therefore expected to drive the growth of the market.

Further, the report states that the lack of availability of diagnostic procedures for the identification of the disorder is a major challenge faced by the bipolar disorder therapeutics market.

Key vendors: 

• Allergan
• AstraZeneca
• BMS
• Eli Lilly
• GlaxoSmithKline
• Janssen Pharmaceuticals

Other prominent vendors: 

• AbbVie
• Abital Pharma
• Astellas
• Convergence Pharmaceuticals
• D Pharm
• Delpor
• Gedeon Richter
• H. Lundbeck
• Intra-Cellular Therapies
• Novartis
• Noven Pharmaceuticals
• Omeros Corporation
• Otsuka
• Pfizer
• PNBDevCo
• Reviva Pharmaceuticals
• SK Biopharmaceuticals
• Sunovion Pharmaceutical

Key Topics Covered: 

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Market research methodology 

PART 04: Introduction

PART 05: Disease overview

PART 06: Pipeline analysis 

PART 07: Market landscape 

PART 08: Market segmentation by drug class 

PART 09: Market segmentation by mechanism of action 

PART 10: Geographical segmentation 

PART 11: Market drivers 

PART 12: Impact of drivers 

PART 13: Market challenges 

PART 14: Impact of drivers and challenges 

PART 15: Market trends 

PART 16: Vendor landscape 

PART 17: Key vendor analysis 

Companies Mentioned:

• Allergan
• AstraZeneca
• BMS
• Eli Lilly
• GSK
• Janssen Pharmaceuticals
• AbbVie
• Abital Pharma
• Astellas
• Convergence Pharmaceuticals
• D Pharm
• Delpor
• Gedeon Richter
• H. Lundbeck
• Intra-Cellular Therapies
• Novartis
• Noven Pharmaceuticals
• Omeros Corporation
• Otsuka
• Pfizer
• PNBDevCo
• Reviva Pharmaceuticals
• SK Biopharmaceuticals
• Sunovion Pharmaceutical.

For more information visit http://www.researchandmarkets.com/research/h5sn6k/global_bipolar

About Research and Markets:    

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: 
Laura Wood
+353-1-481-1716
press@researchandmarkets.net